海森药业
(001367)
| 流通市值：26.04亿 | | | 总市值：32.62亿 |
| 流通股本：1.22亿 | | | 总股本：1.52亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 250,890,339.55 | 107,192,930.67 | 532,259,379.46 | 358,867,170.35 |
| 营业收入 | 250,890,339.55 | 107,192,930.67 | 532,259,379.46 | 358,867,170.35 |
| 二、营业总成本 | 180,469,420.2 | 76,950,988.07 | 381,201,958.18 | 259,594,428.66 |
| 营业成本 | 134,035,500.97 | 55,538,790.61 | 289,549,165.67 | 195,283,235.55 |
| 税金及附加 | 2,821,411.51 | 1,358,235.04 | 4,579,765.7 | 3,602,364.85 |
| 销售费用 | 7,913,818.05 | 2,858,882.95 | 16,199,675.79 | 11,177,580.16 |
| 管理费用 | 16,436,410.8 | 7,269,124.41 | 37,032,877.28 | 25,676,117.04 |
| 研发费用 | 18,202,261.39 | 9,400,697.54 | 38,860,884.85 | 28,166,061.59 |
| 财务费用 | 1,060,017.48 | 525,257.52 | -5,020,411.11 | -4,310,930.53 |
| 其中:利息费用 | 152,714.28 | 76,703.13 | 346,049.03 | 259,161.14 |
| 其中:利息收入 | 1,535,950.15 | 946,105.03 | 5,682,222.2 | 3,998,299.29 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | 1,695,000 | - |
| 加:投资收益 | 2,050,237.74 | 1,273,525.41 | 5,017,801.56 | 2,661,019.51 |
| 资产减值损失(新) | -122,179.5 | -60,712.82 | -698,845.1 | -400,198.32 |
| 信用减值损失(新) | 1,652,254.33 | 1,325,975.07 | -2,752,614.01 | -566,718.5 |
| 其他收益 | 884,564.78 | 344,807.66 | 2,526,733.97 | 1,225,917.9 |
| 四、营业利润 | 74,885,796.7 | 33,125,537.92 | 156,845,497.7 | 102,192,762.28 |
| 加:营业外收入 | 202,304.56 | 180,190.36 | 584,787.81 | 571,268.1 |
| 减:营业外支出 | 153,967.5 | 151,148.35 | 673,268.02 | 397,454.54 |
| 五、利润总额 | 74,934,133.76 | 33,154,579.93 | 156,757,017.49 | 102,366,575.84 |
| 减:所得税费用 | 9,198,782.62 | 4,246,135.64 | 20,877,351.71 | 14,156,958.55 |
| 六、净利润 | 65,735,351.14 | 28,908,444.29 | 135,879,665.78 | 88,209,617.29 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 65,735,351.14 | 28,908,444.29 | 135,879,665.78 | 88,209,617.29 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 65,735,351.14 | 28,908,444.29 | 135,879,665.78 | 88,209,617.29 |
| 扣除非经常损益后的净利润 | 63,199,682.5 | 27,508,175.47 | 128,101,268.76 | 84,757,978.97 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.44 | 0.19 | 0.91 | 0.59 |
| (二)稀释每股收益 | 0.43 | 0.19 | 0.89 | 0.58 |
| 九、综合收益总额 | 65,735,351.14 | 28,908,444.29 | 135,879,665.78 | 88,209,617.29 |
| 归属于母公司股东的综合收益总额 | 65,735,351.14 | 28,908,444.29 | 135,879,665.78 | 88,209,617.29 |
| 公告日期 | 2026-08-21 | 2026-04-28 | 2026-03-26 | 2025-10-22 |
| 审计意见(境内) | | | 标准无保留意见 | |